Organelles

May 19, 2020

Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases

Feb 19, 2020

2020 Global Primary Ciliary Dyskinesia (PCD) Pipeline Landscape Overview

Nov 27, 2018

15th Annual WORLDSymposium 2019 Scientific Meeting February 4 - 8, 2019 Preliminary Program Announced

Nov 12, 2018

Late-Breaking Abstract Submissions Are Now Open for the 15th Annual WORLDSymposium 2019 Research Conference in Orlando, Florida, USA

Apr 04, 2018

Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform

Jan 04, 2018

Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates

Nov 21, 2017

Arvinas and Macroceutics Establish DEL Screening Collaboration on Undruggable Targets

Nov 15, 2017

Arvinas Expands Strategic License Agreement with Genentech

Oct 31, 2017

Kezar Life Sciences to Present Multiple Abstracts at the 2017 American College of Rheumatology Annual Meeting in San Diego

Oct 30, 2017

Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies

Jul 25, 2017

Kezar Life Sciences Announces Successful Completion of Phase 1a Study and Secures $50 Million in Series B Financing